Volume 143, Issue 2, Pages (October 2010)

Slides:



Advertisements
Similar presentations
Volume 14, Issue 1, Pages (January 2014)
Advertisements

Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors  Kazutoshi Takahashi, Shinya Yamanaka  Cell 
Volume 20, Issue 13, Pages (September 2017)
Volume 2, Issue 4, Pages (April 2008)
Francesca Ficara, Mark J. Murphy, Min Lin, Michael L. Cleary 
Establishment of Endoderm Progenitors by SOX Transcription Factor Expression in Human Embryonic Stem Cells  Cheryle A. Séguin, Jonathan S. Draper, Andras.
Volume 11, Issue 2, Pages (August 2012)
Volume 5, Issue 6, Pages (December 2013)
by Holger Weishaupt, Mikael Sigvardsson, and Joanne L. Attema
Roger B. Deal, Steven Henikoff  Developmental Cell 
Volume 58, Issue 2, Pages (April 2015)
Volume 68, Issue 1, Pages e5 (October 2017)
Volume 146, Issue 6, Pages (September 2011)
Volume 58, Issue 6, Pages (June 2015)
Revealing Global Regulatory Perturbations across Human Cancers
Volume 26, Issue 4, Pages (October 2014)
Volume 23, Issue 4, Pages (April 2018)
Volume 28, Issue 2, Pages (August 2015)
Volume 33, Issue 4, Pages (February 2009)
Volume 13, Issue 1, Pages (July 2013)
Volume 18, Issue 4, Pages (October 2010)
Rudolf Jaenisch, Richard Young  Cell 
Volume 2, Issue 2, Pages (February 2008)
Volume 43, Issue 5, Pages (September 2011)
Volume 149, Issue 7, Pages (June 2012)
Cell-Type-Based Analysis of MicroRNA Profiles in the Mouse Brain
Volume 7, Issue 3, Pages (September 2016)
Volume 135, Issue 4, Pages (November 2008)
Volume 23, Issue 1, Pages 9-22 (January 2013)
Volume 6, Issue 4, Pages (April 2010)
Volume 7, Issue 4, Pages (May 2014)
Revealing Global Regulatory Perturbations across Human Cancers
Vanessa Brès, Tomonori Yoshida, Loni Pickle, Katherine A. Jones 
Volume 56, Issue 5, Pages (December 2014)
Volume 13, Issue 1, Pages (July 2013)
Volume 46, Issue 1, Pages (April 2012)
Wei Jiang, Yuting Liu, Rui Liu, Kun Zhang, Yi Zhang  Cell Reports 
Volume 9, Issue 5, Pages (November 2017)
Volume 136, Issue 2, Pages (January 2009)
Volume 9, Issue 4, Pages (November 2014)
Volume 21, Issue 6, Pages e6 (December 2017)
Volume 132, Issue 6, Pages (March 2008)
An RNAi Screen of Chromatin Proteins Identifies Tip60-p400 as a Regulator of Embryonic Stem Cell Identity  Thomas G. Fazzio, Jason T. Huff, Barbara Panning 
Volume 13, Issue 1, Pages (October 2015)
Volume 122, Issue 6, Pages (September 2005)
Volume 66, Issue 4, Pages e4 (May 2017)
Volume 35, Issue 2, Pages (August 2011)
Xudong Wu, Jens Vilstrup Johansen, Kristian Helin  Molecular Cell 
Volume 55, Issue 5, Pages (September 2014)
Volume 55, Issue 5, Pages (September 2014)
Volume 42, Issue 6, Pages (June 2011)
Volume 118, Issue 2, Pages (July 2004)
H2B Ubiquitylation Promotes RNA Pol II Processivity via PAF1 and pTEFb
Volume 7, Issue 2, Pages (August 2010)
Volume 16, Issue 2, Pages (February 2015)
Kiran Batta, Magdalena Florkowska, Valerie Kouskoff, Georges Lacaud 
Volume 1, Issue 3, Pages (September 2007)
Brandon Ho, Anastasia Baryshnikova, Grant W. Brown  Cell Systems 
Volume 167, Issue 2, Pages e9 (October 2016)
Volume 29, Issue 3, Pages (March 2016)
CNOT3-Dependent mRNA Deadenylation Safeguards the Pluripotent State
Volume 17, Issue 4, Pages (October 2015)
Fig. 3 Conserved genomic association of PRC1 activity in different leukemic cells. Conserved genomic association of PRC1 activity in different leukemic.
Volume 17, Issue 3, Pages (October 2016)
Volume 64, Issue 5, Pages (December 2016)
Volume 2, Issue 3, Pages (March 2016)
Volume 9, Issue 3, Pages (November 2014)
Volume 58, Issue 2, Pages (April 2015)
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor α-Bound Enhancers  Julia B. Carleton, Kristofer.
Genome-wide Functional Analysis Reveals Factors Needed at the Transition Steps of Induced Reprogramming  Chao-Shun Yang, Kung-Yen Chang, Tariq M. Rana 
Presentation transcript:

Volume 143, Issue 2, Pages 313-324 (October 2010) A Myc Network Accounts for Similarities between Embryonic Stem and Cancer Cell Transcription Programs  Jonghwan Kim, Andrew J. Woo, Jianlin Chu, Jonathan W. Snow, Yuko Fujiwara, Chul Geun Kim, Alan B. Cantor, Stuart H. Orkin  Cell  Volume 143, Issue 2, Pages 313-324 (October 2010) DOI: 10.1016/j.cell.2010.09.010 Copyright © 2010 Elsevier Inc. Terms and Conditions

Cell 2010 143, 313-324DOI: (10.1016/j.cell.2010.09.010) Copyright © 2010 Elsevier Inc. Terms and Conditions

Figure 1 Myc-Centered Protein-Protein Interaction Network in ES Cells (A) Schematic representation of the strategy for mapping a Myc-centered protein-protein interaction network in ES cells. High-confidence components of multiprotein complexes were identified and listed in the table. Pink cells represent NuA4 complex proteins. (B) Depiction of the features of the Myc-centered protein-protein interaction network. Proteins with green labels are biotin tagged proteins and pink circles indicate NuA4 complex proteins. Proteins identified by multiple biotin-tagged factors are shown. Entire protein interaction network is shown in Figure S1C. See also Table S1. (C) Validation of the interaction network by coimmunoprecipitation. Cell 2010 143, 313-324DOI: (10.1016/j.cell.2010.09.010) Copyright © 2010 Elsevier Inc. Terms and Conditions

Figure 2 Myc-Centered Protein-DNA Interaction Network in ES Cells (A) Representative view of Myc, Max, Dmap1, Tip60, E2F4, and Gcn5 occupancy at the target loci. (B) Number of target promoters bound by each factor or associated with each histone modification signature. Blue represents factors or histone signatures involved in PRC complexes. Red represents factors involved in ES cell core factors, and green represents Myc and Myc- related factors or histone signatures (D and E). See also Figure S2 and Table S2. (C) Relative position of chromosomal target loci of each factor in the Myc cluster (upper panel) and Core cluster (bottom panel) shown in (B) and (C) to the TSS. (D) Target correlation map: The degree of target co-occupancy of each pair of factors (either transcription factor or histone modification signature) is shown. Yellow indicates more frequent colocalization of each pair of factors. (E) Median distance map: Median distances between the loci co-occupied by two tested factors (except PRC complex proteins) shown in (D). Yellow indicates closer colocalization. Cell 2010 143, 313-324DOI: (10.1016/j.cell.2010.09.010) Copyright © 2010 Elsevier Inc. Terms and Conditions

Figure 3 Histone Modification Signatures on the Target Promoters of Myc Cluster Proteins (A) Histone marks on the target promoters of each factor in the Myc cluster. “All” represents all promoters. (B) Histone marks and target co-occupancy of seven factors in Myc cluster (Myc, Max, nMyc, Dmap1, E2F1, E2F4, and Zfx). Cell 2010 143, 313-324DOI: (10.1016/j.cell.2010.09.010) Copyright © 2010 Elsevier Inc. Terms and Conditions

Figure 4 ES Cell Modules (A) Gene expression profiles (log2, left y axis) upon J1 ES cell differentiation (wild-type ES cells: ES, differentiated ES cells for 14 days: dES day 14) are shown as moving window averaged lines (ES; red line, dES day 14; blue line, bin size 100 and step size 1). Randomized genes are sorted (x axis) by the target co-occupancy of seven factors in the Myc cluster (right y axis). Black bar represents target genes co-occupied by at least six factors among the seven factors in the Myc cluster. (B) Enrichment of KEGG pathways. All Myc target genes (gray bars, total 3733 genes) and genes co-occupied by at least six factors among the seven factors tested marked by black bar in (A) (black bars, total 1756 genes). See also Figures S3A and S3B and Table S3. (C) ES cell modules: Three ES cell modules are defined based on the target co-occupancy within each cluster shown in Figure 2D. See also Table S3. (D) GSEA analyses show the gene activity of the three ES cell modules (Core, PRC, and Myc modules) as well as the previously defined ESC-like module (Wong et al., 2008a) upon ES cell differentiation (wild-type ES cells; ES versus 14 days differentiated ES cells; dES). (E) Average gene expression values (log2) of each module (C) are tested upon ES cell differentiation (ES day0, dES day2, dES day7, and dES day14, respectively). Data are represented as mean ± SEM. See also Figure S2B and Figure S3C. Cell 2010 143, 313-324DOI: (10.1016/j.cell.2010.09.010) Copyright © 2010 Elsevier Inc. Terms and Conditions

Figure 5 Module Activity in Various Cells (A) Average gene expression values (log2) (Sridharan et al., 2009) of ES cell modules (Core, PRc, and Myc) and previously defined ESC-like module are tested in ES cells (ES), iPS cells (iPS), MEFs (MEF), and partial iPS cells (piPS). See also Figure S3D. (B) Average gene expression values (log2) (Bild et al., 2006) of each module tested in (A) upon induction of Myc in human epithelial cells (Myc induction) and in control cells (WT). Human orthologs of genes in three ES cell modules are tested (listed in Table S3) and data are represented as mean ± SEM (A and B). Cell 2010 143, 313-324DOI: (10.1016/j.cell.2010.09.010) Copyright © 2010 Elsevier Inc. Terms and Conditions

Figure 6 ES Cell Modules in Mouse MLL Myeloid Leukemia Models (A) Average gene expression values (log2) of ES cell modules and the previously defined ESC-like module are tested in various mouse models of acute myeloid leukemia (AML) initiated by MLL-AF9, MLL-ENL, MLL-AF10, MLL-AF1p, and MLL-GAS7 (Somervaille et al., 2009). (B) Average gene expression values (log2) of each module are tested in a c-kit high MLL-AF10 leukemia cell population (MLL-AF10 c-kit high) and a c-kit low MLL-AF10 leukemia cell population (MLL-AF10 c-kit low) (Somervaille et al., 2009). Data are represented as mean ± SEM (A and B). See also Figure S4. Cell 2010 143, 313-324DOI: (10.1016/j.cell.2010.09.010) Copyright © 2010 Elsevier Inc. Terms and Conditions

Figure 7 ES Cell Modules in Human Cancers (A and B) Average gene expression values (log2) of ES cell modules and previously defined ESC-like module are tested in human bladder carcinoma samples including superficial (SUP), and invasive carcinomas (INV), as well as normal urothelium (NU) as a control group (marked by black bars) (Sanchez-Carbayo et al., 2006). Each column represents one patient sample (total 157 samples) (A). Averaged module activities within the sample group (NU, INV, and SUP) (B). Data are represented as mean ± SEM. (C–E) Average gene expression values (log2) of ES cell Core (C) and Myc (D) module are tested from 97 human breast cancer patient samples (van't Veer et al., 2002). (C) Core module activities were calculated, and top and bottom 20% of samples (19 samples each) were further analyzed. Bar graph represents the corresponding interval to metastases (months, bottom panel). (D) Samples showing top and bottom 20% of Myc module activity were further analyzed. Bar graph represents the corresponding interval to metastases (months) for each patient (bottom panel). (E) For each tested group (C and D), interval to distant metastases is calculated as mean ± SEM, and p values are from Student's t tests. See also Figure S5. Cell 2010 143, 313-324DOI: (10.1016/j.cell.2010.09.010) Copyright © 2010 Elsevier Inc. Terms and Conditions

Figure S1 Myc-Centered Protein-Protein Interaction Network, Related to Figure 1 (A) Expression analysis of pluripotency and differentiation marker genes is performed using cell lines expressing biotin-tagged proteins. Relative gene expression levels compared to the levels in BirA expressing ES cells are shown. Data are represented as mean ± SEM. (B) Input nuclear extract is treated with DNaseI/RNaseA for 1 hour, and the intercalating agent ethidium bromide is added to eliminate indirect protein-protein interaction mediated by nucleic acids. Strong protein-protein interactions of Dmap1 and other factors shown in Figure 1C are essentially recreated by co-immunoprecipitation. (C) Depiction of the features of the Myc-centered protein-protein interaction network (left panel) and the previously identified Nanog-centered protein-protein interaction network (right panel) in ES cells. Proteins with green and red circles represent the biotin-tagged proteins used in affinity purifications. (D and E) shRNA-based knockdown of Myc, Gcn5, and NuA4 complex proteins including Dmap1, Trrap, Ep400, Tip60, Ruvb2, and Ing3 is performed in ES cells. Relative expression of ES cell marker genes (Oct4, Sox2, Nanog, and Zfp42) and Myc/NuA4 complex genes (Dmap1, Ep400, Trrap, and Myc) upon knockdown of each factor is shown (D). Data are represented as mean ± SEM. ES cell morphology upon knockdown of each factor is shown (E). Empty (empty vector), GFP, and wtES (untreated) serve as controls. Cell 2010 143, 313-324DOI: (10.1016/j.cell.2010.09.010) Copyright © 2010 Elsevier Inc. Terms and Conditions

Figure S2 Myc Cluster and Gene Sets Cobound by Factors in Myc Cluster, Related to Figure 2 and Figure 4 (A) Hierarchical clustering of factors in the Myc cluster shown in Figure 2 based on their target co-occupancy. Total 12154 genes which are targets of at least one of the 12 factors in the Myc cluster are tested. (B) Targets co-occupied by different combinations of factors in the Myc cluster (Figure 2) are identified (listed in Table S3), and average gene expression values (log2) of gene sets upon ES cell differentiation are plotted using the data set used in Figure 4D. Tested gene sets are 1) Myc, Max, Dmap1, and Tip60 common targets, 2) Myc module + Trim28, Cnot3 (Myc, Max, nMyc, Dmap1, E2F1, E2F4, Zfx, Trim28, and Cnot3 common targets), 3) Myc module (Myc, Max, nMyc, Dmap1, E2F1, E2F4, and Zfx common targets), 4) 7 factors in Myc module and Rex1 common targets, 5) Myc, Max, Dmap1, nMyc, E2F1, and Zfx common targets, 6) all Myc targets, 7) all E2F4 targets, and 8) all E2F1 targets. Data are represented as mean ± SEM. Cell 2010 143, 313-324DOI: (10.1016/j.cell.2010.09.010) Copyright © 2010 Elsevier Inc. Terms and Conditions

Figure S3 ES Cell Modules, Related to Figure 4 and Figure 5 (A and B) Enrichment of pathways and Gene Ontology (GO) is tested using two groups of genes; genes in the Core module (A), and the PRC module (B). (C and D) Averaged gene expression values (log2) of ES cell modules upon ES cell differentiation shown in Figure 4D (C) as well as in various cell types, such as ES cells (ES), iPS cells (iPS), MEFs (MEF), and partial iPS cells (piPS) shown in Figure 5A (D) are re-plotted using individual gene activities as heat map graphs. Total 772 genes (C) and 1004 genes (D) are shown. Cell 2010 143, 313-324DOI: (10.1016/j.cell.2010.09.010) Copyright © 2010 Elsevier Inc. Terms and Conditions

Figure S4 Nanog and Oct4 Expression Levels upon Myc Induction in Human Epithelial Cells and ES Cell Module Activities in Hematopoietic Stem Cells, Related to Figure 5B and Figure 6 (A) mRNA expression levels (log2) of two individual ES cell core factors, Nanog and Oct4 are shown using the same expression data set used in Figure 5B. Individual array experiments (depicted as numbers) are shown. Level of Myc mRNA is also shown as a control. (B) Average gene expression values (log2) of ES cell modules (Core, PRC, and Myc) are tested in long-term hematopoietic stem cells (LT-HSC: Lin-cKit+Sca1+CD34-CD135-), and short-term hematopoietic stem cells (ST-HSC: Lin-cKit+Sca1+CD34+CD135-) using a previously published expression array data set (Ficara et al., 2008). Individual arrays are used for the analysis, and data are represented as mean ± SEM. Cell 2010 143, 313-324DOI: (10.1016/j.cell.2010.09.010) Copyright © 2010 Elsevier Inc. Terms and Conditions

Figure S5 ES Cell Core and Myc Module Activities in Human Breast Cancer Subtypes, Related to Figure 7 (A) Using the data set shown in Figure 7D, average gene expression values (log2) of the previously defined Core ESC-like gene module (Core ESC-like), and mouse ESC-like gene module (mouse ESC-like) are calculated and plotted with the Myc module activity (Myc). Black bars (bottom panel) represent the corresponding interval to metastasis (months; same as shown in Figure 7D bottom). (B and C) Average gene expression values (log2) of ES cell modules (Core, PRC and Myc) are tested using previously published human breast cancer subtype data including basal-like cancers (Basal), non-basal like cancers (Non-basal), and control samples (Richardson et al., 2006). Module activities of each patient sample (total 45 samples) are shown (B). Averaged module activities within the sample groups (Control, Non-basal, and Basal) are shown as mean ± SEM (C). (D) For each of the tested groups shown in Figures 7C and 7D (total 4 groups; samples with the top 20% and bottom 20% of Core module activity, and samples with the top 20% and bottom 20% of Myc module activity), percentage of estrogen receptor (ER) positive samples in each group are shown. P-values are calculated using Student's T-tests. (E) Using an independently published data set containing 96 human breast cancer patients (Hu et al., 2006), Core and Myc module activities (average gene expression values (log2)) are calculated. Four groups of samples (Core module activity: top and bottom 20% each; Myc module activity: top and bottom 20%, each; 19 samples in each group) are further analyzed. Percentage of corresponding ER positive samples (left panel), basal-like tumor samples (middle panel), and luminal tumor samples (right panel) within each group is plotted. P-values derived using Student's T-tests. Cell 2010 143, 313-324DOI: (10.1016/j.cell.2010.09.010) Copyright © 2010 Elsevier Inc. Terms and Conditions